Skip to main content
Erschienen in: Diabetologia 5/2016

08.02.2016 | Article

Incidence of register-based diabetes 10 years after a stepwise diabetes screening programme: the ADDITION-Denmark study

verfasst von: Signe S. Rasmussen, Nanna B. Johansen, Daniel R. Witte, Knut Borch-Johnsen, Annelli Sandbaek, Torsten Lauritzen, Marit E. Jørgensen

Erschienen in: Diabetologia | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Screening programmes for type 2 diabetes inevitably find more people at high risk of developing diabetes than people with undiagnosed prevalent diabetes. We describe the incidence of diabetes for risk groups according to advancement in a screening process.

Methods

In 2001–2006, a diabetes screening programme based on the Danish diabetes risk score and measures of HbA1c and glucose was carried out in Danish general practices. The present study includes 13,249 individuals with low diabetes risk scores and 22,726 with high diabetes risk scores but no diabetes according to WHO 1999 criteria. Seven incremental levels of diabetes risk were defined and followed for incident diabetes recorded in the Danish National Diabetes Register until December 2012. For each group, cumulative diabetes incidence was calculated. Incidence rates and rate ratios were estimated by Poisson regression analyses.

Results

After 10 years of follow-up 1,164 new diabetes cases were registered. Incidence rates were 1.0, 4.2, 14.5, 28.8 and 52.6 per 1,000 person-years in individuals at low risk and in those with normal glucose tolerance, impaired fasting glucose, impaired glucose tolerance and one diabetic glucose value, respectively. For each step in the screening algorithm, the risk of developing diabetes was higher than in the previous step.

Conclusions/interpretation

The risk of developing clinical diabetes in people who screen negative for diabetes depends on the level of risk stratification at screening, even at lower risk levels. This risk increases markedly in the presence of impaired glucose regulation. These results can inform policy recommendations concerning prevention strategies following screening.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403CrossRefPubMed Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403CrossRefPubMed
2.
Zurück zum Zitat Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544CrossRefPubMed Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544CrossRefPubMed
3.
Zurück zum Zitat Chiasson JL, Josse RG, Gomis R et al (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072–2077CrossRefPubMed Chiasson JL, Josse RG, Gomis R et al (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072–2077CrossRefPubMed
4.
Zurück zum Zitat Lindstrom J, Peltonen M, Eriksson JG et al (2013) Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 56:284–293CrossRefPubMed Lindstrom J, Peltonen M, Eriksson JG et al (2013) Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 56:284–293CrossRefPubMed
5.
Zurück zum Zitat Costa B, Barrio F, Cabre JJ et al (2012) Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention. Diabetologia 55:1319–1328CrossRefPubMed Costa B, Barrio F, Cabre JJ et al (2012) Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention. Diabetologia 55:1319–1328CrossRefPubMed
6.
Zurück zum Zitat Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K, Steering Group of the National Diabetes Register (2008) The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 51:2187–2196CrossRefPubMed Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K, Steering Group of the National Diabetes Register (2008) The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 51:2187–2196CrossRefPubMed
7.
Zurück zum Zitat Nichols GA, Schroeder EB, Karter AJ et al (2015) Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM project. Am J Epidemiol 181:32–39CrossRefPubMedPubMedCentral Nichols GA, Schroeder EB, Karter AJ et al (2015) Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM project. Am J Epidemiol 181:32–39CrossRefPubMedPubMedCentral
8.
9.
Zurück zum Zitat Rathmann W, Strassburger K, Heier M et al (2009) Incidence of type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diabet Med 26:1212–1219CrossRefPubMed Rathmann W, Strassburger K, Heier M et al (2009) Incidence of type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diabet Med 26:1212–1219CrossRefPubMed
10.
Zurück zum Zitat Bonora E, Kiechl S, Willeit J et al (2004) Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 53:1782–1789CrossRefPubMed Bonora E, Kiechl S, Willeit J et al (2004) Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 53:1782–1789CrossRefPubMed
11.
Zurück zum Zitat Valdes S, Botas P, Delgado E, Alvarez F, Cadorniga FD (2007) Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study. Diabetes Care 30:2258–2263CrossRefPubMed Valdes S, Botas P, Delgado E, Alvarez F, Cadorniga FD (2007) Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study. Diabetes Care 30:2258–2263CrossRefPubMed
12.
Zurück zum Zitat Soriguer F, Rojo-Martinez G, Almaraz MC et al (2008) Incidence of type 2 diabetes in southern Spain (Pizarra Study). Eur J Clin Invest 38:126–133CrossRefPubMed Soriguer F, Rojo-Martinez G, Almaraz MC et al (2008) Incidence of type 2 diabetes in southern Spain (Pizarra Study). Eur J Clin Invest 38:126–133CrossRefPubMed
13.
Zurück zum Zitat Forouhi NG, Luan J, Hennings S, Wareham NJ (2007) Incidence of type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. Diabet Med 24:200–207CrossRefPubMed Forouhi NG, Luan J, Hennings S, Wareham NJ (2007) Incidence of type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. Diabet Med 24:200–207CrossRefPubMed
14.
Zurück zum Zitat Morris DH, Khunti K, Achana F et al (2013) Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 56:1489–1493CrossRefPubMed Morris DH, Khunti K, Achana F et al (2013) Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 56:1489–1493CrossRefPubMed
15.
Zurück zum Zitat Gerstein HC, Santaguida P, Raina P et al (2007) Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78:305–312CrossRefPubMed Gerstein HC, Santaguida P, Raina P et al (2007) Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78:305–312CrossRefPubMed
16.
Zurück zum Zitat Rasmussen S, Glümer C, Sandbaek A, Lauritzen T, Borch-Johnsen K (2008) Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark. Diabetologia 51:249–257CrossRefPubMed Rasmussen S, Glümer C, Sandbaek A, Lauritzen T, Borch-Johnsen K (2008) Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark. Diabetologia 51:249–257CrossRefPubMed
17.
Zurück zum Zitat Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BHR, Rutten G (2000) The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes (Lond) 24(Suppl 3):S6–S11CrossRef Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BHR, Rutten G (2000) The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes (Lond) 24(Suppl 3):S6–S11CrossRef
18.
Zurück zum Zitat Glümer C, Carstensen B, Sandbaek A et al (2004) A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 27:727–733CrossRefPubMed Glümer C, Carstensen B, Sandbaek A et al (2004) A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 27:727–733CrossRefPubMed
19.
Zurück zum Zitat World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. World Health Organization, Geneva World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. World Health Organization, Geneva
20.
Zurück zum Zitat Christensen JO, Sandbaek A, Lauritzen T, Borch-Johnsen K (2004) Population-based stepwise screening for unrecognised type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia 47:1566–1573CrossRefPubMed Christensen JO, Sandbaek A, Lauritzen T, Borch-Johnsen K (2004) Population-based stepwise screening for unrecognised type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia 47:1566–1573CrossRefPubMed
21.
Zurück zum Zitat Carstensen B, Kristensen JK, Marcussen MM, Borch-Johnsen K (2011) The National Diabetes Register. Scand J Public Health 39:58–61CrossRefPubMed Carstensen B, Kristensen JK, Marcussen MM, Borch-Johnsen K (2011) The National Diabetes Register. Scand J Public Health 39:58–61CrossRefPubMed
22.
Zurück zum Zitat Green A, Sortso C, Jensen PB, Emneus M (2015) Validation of the Danish National Diabetes Register. Clin Epidemiol 7:5–15PubMedPubMedCentral Green A, Sortso C, Jensen PB, Emneus M (2015) Validation of the Danish National Diabetes Register. Clin Epidemiol 7:5–15PubMedPubMedCentral
23.
Zurück zum Zitat Glümer C, Jørgensen T, Borch-Johnsen K (2003) Prevalences of diabetes and impaired glucose regulation in a Danish population. The Inter99 study. Diabetes Care 26:2335–2340CrossRefPubMed Glümer C, Jørgensen T, Borch-Johnsen K (2003) Prevalences of diabetes and impaired glucose regulation in a Danish population. The Inter99 study. Diabetes Care 26:2335–2340CrossRefPubMed
24.
Zurück zum Zitat Nielsen AA, Christensen H, Lund ED, Christensen C, Brandslund I, Green A (2014) Diabetes mortality differs between registers due to various disease definitions. Dan Med J 61:A4840PubMed Nielsen AA, Christensen H, Lund ED, Christensen C, Brandslund I, Green A (2014) Diabetes mortality differs between registers due to various disease definitions. Dan Med J 61:A4840PubMed
25.
Zurück zum Zitat Danish Health and Medicines Authority (2007) The National Danish Diabetes Register. Available from sundhedsstyrelsen.dk/publ/tidsskrifter/nyetal/pdf/2009/01_09.pdf. Accessed 5 January 2015 Danish Health and Medicines Authority (2007) The National Danish Diabetes Register. Available from sundhedsstyrelsen.dk/publ/tidsskrifter/nyetal/pdf/2009/01_09.pdf. Accessed 5 January 2015
26.
Zurück zum Zitat Jensen ML, Jorgensen ME, Hansen EH, Aagaard L, Carstensen B (2014) A multistate model and an algorithm for measuring long-term adherence to medication: a case of diabetes mellitus type 2. Value Health 17:266–274CrossRefPubMed Jensen ML, Jorgensen ME, Hansen EH, Aagaard L, Carstensen B (2014) A multistate model and an algorithm for measuring long-term adherence to medication: a case of diabetes mellitus type 2. Value Health 17:266–274CrossRefPubMed
27.
Zurück zum Zitat Royal College of General Practitioners in Denmark. Type 2 diabetes in general practice—an evidence based guideline. Royal College of General Practioners, Copenhagen, Denmark Royal College of General Practitioners in Denmark. Type 2 diabetes in general practice—an evidence based guideline. Royal College of General Practioners, Copenhagen, Denmark
28.
Zurück zum Zitat Royal College of General Practitioners in Denmark. Prevention of ischemic cardiovascular disease in general practice. Royal College of General Practioners, Copenhagen, Denmark Royal College of General Practitioners in Denmark. Prevention of ischemic cardiovascular disease in general practice. Royal College of General Practioners, Copenhagen, Denmark
29.
Zurück zum Zitat American Diabetes Association (2015) (2) Classification and diagnosis of diabetes. Diabetes care 38 Suppl: S8-S16 American Diabetes Association (2015) (2) Classification and diagnosis of diabetes. Diabetes care 38 Suppl: S8-S16
30.
Zurück zum Zitat Dunkley AJ, Bodicoat DH, Greaves CJ et al (2014) Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care 37:922–933CrossRefPubMed Dunkley AJ, Bodicoat DH, Greaves CJ et al (2014) Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care 37:922–933CrossRefPubMed
Metadaten
Titel
Incidence of register-based diabetes 10 years after a stepwise diabetes screening programme: the ADDITION-Denmark study
verfasst von
Signe S. Rasmussen
Nanna B. Johansen
Daniel R. Witte
Knut Borch-Johnsen
Annelli Sandbaek
Torsten Lauritzen
Marit E. Jørgensen
Publikationsdatum
08.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 5/2016
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-3887-6

Weitere Artikel der Ausgabe 5/2016

Diabetologia 5/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.